XML 127 R107.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation Share-Based Compensation - Restricted Stock and Performance Shares (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 22.50 $ 22.23
Ending balance, Weighted Average Grant Date Fair Value $ 29.56 $ 22.50
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 138  
Granted, Number of Share Units Outstanding 34  
Vested, Number of Share Units Outstanding 63  
Forfeited, Number of Share Units Outstanding (2)  
Ending balance, Number of Share Units Outstanding 107 138
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 72.59  
Granted, Weighted Average Grant Date Fair Value 91.36  
Vested, Weighted Average Grant Date Fair Value 70.79  
Forfeited, Weighted Average Grant Date Fair Value 82.09  
Ending balance, Weighted Average Grant Date Fair Value $ 79.37 $ 72.59
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 112  
Granted, Number of Share Units Outstanding 57  
Net increase due to estimated performance, Number of Share Units Outstanding (22)  
Vested, Number of Share Units Outstanding 58  
Forfeited, Number of Share Units Outstanding (1)  
Ending balance, Number of Share Units Outstanding 88 112
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 76.03  
Granted, Weighted Average Grant Date Fair Value 87.45  
Net increase due to estimated performance, Weighted Average Grant Date Fair Value 84.78  
Vested, Weighted Average Grant Date Fair Value 71.98  
Forfeited, Weighted Average Grant Date Fair Value 87.06  
Ending balance, Weighted Average Grant Date Fair Value $ 83.79 $ 76.03